chrisvoncsefalvay/vaers-outcomes huggingface dataset:
100F temperature; chills; nausea; Headache; overall body ache; feels tired; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PYREXIA (100F temperature), CHILLS (chills), NAUSEA (nausea), HEADACHE (Headache) and MYALGIA (overall body ache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced PYREXIA (100F temperature), CHILLS (chills), NAUSEA (nausea), HEADACHE (Headache), MYALGIA (overall body ache) and FATIGUE (feels tired). At the time of the report, PYREXIA (100F temperature), CHILLS (chills), NAUSEA (nausea), HEADACHE (Headache), MYALGIA (overall body ache) and FATIGUE (feels tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Treatment information was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
1/2 -1 hour after vaccination - started to feel very warm. 1.1/2 hours after the vaccine, started to feel nausea. left work 2.1/2 hours after vaccine felt very nauseated and vomited. symptoms then started to subside - but slight headache started.
A non-serious spontaneous report of administration of expired FLUMIST was received from a nurse concerning a 28-year-old male. Neither medical history nor concomitant medications were reported. On 25-Feb-2009, the patient received expired FLUMIST vaccine. The vaccine had an expiration date of 11-Jan-2009. As of 18-Mar-2009, there was no adverse events associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. Based on the results of the investigation, the root cause of the medication errors were caused by 1) customers not discarding product from previous season and 2) product expiring during the peak of flu season resulting in some medication errors that occurred shortly after the product expired. Follow-up information was received on 12-May-2009: Product Complaint Investigation results.
A nurse reported that an unspecified pt, with a history of allergy to horse serum, experiened an unspecified reaction subsequent to tetanus toxoid adsorbed, purogenated vaccination. No further info was available at the time of this report.
Pt completed Pfizer COVID vaccine in feb 2021. Pt found COVID + on 5/18/2021 and admitted to the hospital same day for COVID treatment
Patient reports intermittent chest tightness starting ~ 10 mins after getting the vaccine which is gradually improving. Denies associated shortness of breath or pruritic. No rash or swelling on physical exam.
injection site redness; was adrninistered a dose of PROQUAD that bad a temperature excursion.; This spontaneous report was received from a physician and refers to a 15-month-old female patient.  No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On an unknown date in May 2020 (reported as "2 months ago"), the patient was vaccinated with improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD), which was involved in temperature excursion before administration (formulation, strength, dose, frequency, route of administration, lot # and expiration date were not reported) for prophylaxis. The exact temperature excursion was not reported. On an unknown date in May 2020, the patient experienced injection site redness that lasted a month. The hydrocortisone topical product was used as a treatment. The outcome of injection site erythema was reported as resolved.  Causality assessment was not provided.
Patient is only 64 years old but was given High Dose for 65 and older.
Possible hallucinations. Seeing things that are still, moving out of the corner of my eye; This is a spontaneous report from a non-contactable consumer (patient). A 27-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number was not reported), via an unspecified route of administration, administered in arm left on 13Sep2021 10:00 at the age of 27-year-old as dose number unknown, single for covid-19 immunisation. The patient medical history was none and had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and no other medications were received within 2 weeks of vaccination. The patient was not diagnosed with covid prior to vaccination and patient was not tested for COVID-19 post vaccination. The patient experienced possible hallucinations. seeing things that are still, moving out of the corner of my eye on 14Sep2021 12:00. The patient did not receive any treatment in response to the event and patient was not hospitalized. The outcome of event was recovering.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a consumer reports that an unknown number of consumers of unknown ages and genders received a dose of ZOSTAVAX (lot# not reported) of unknown dose and frequencies on unknown dated for unknown indications. The consumer's medical history, concomitant medications, and past drug history were unknown. On 26-OCT-2013, this consumer reported that her friend told her that he knows of other people who had side effects with ZOSTAVAX. Relevant laboratory testing was unknown. As of 26-OCT-2013, it was unknown if the consumers continued ZOSTAVAX and continued to experience side effects with ZOSTAVAX. The relatedness between therapy with ZOSTAVAX and side effects was not reported. Additional information has been requested.
Patient said that they got a shot and 3 days later their arm started hurting and it still hurts.
Patient received COVID 19 initial series of Pfizer 0.5ml on 08/24/2021, 9/14/2021. Patient received a booster dose of Moderna 0.25 ml at Dialysis Clinic on 11/8/2021. Patient did not exhibit any clinical symptoms post administration, denies any complaints up to this time of reporting.
Initial report received from a physician in the USA on 17 April 2007. A  female patient (age, date of birth not reported) developed nausea, fatigue, injection site knot, 3 hours post administration not reported). The next day, the patient also developed fever, "no chills", raised and tender area, muscle ache, joint pain and severe local pain at the injection site, stiff neck, a dime rash on arms and breast and swollen lymph nodes. The physician stated the patient was treated with Allegra and Benadryl, a CBC test was also done and all negative. Her fatigue has resolved, but still has skin sensitivity and aches that has lasted up to 8 to 10 days. It was not reported if the patient recovered.
patient developed Shingles after / 1st dose of Shingrix; This case was reported by a other health professional and described the occurrence of shingles in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows:  The age at vaccination was not reported.  The age group was not reported but was captured as adult as per vaccine indication. The reporter (admin) said the patient developed Shingles after receiving 1st dose of Shingrix. The reporter consent to follow up.
Hand of arm that vaccination was administered in began hurting, tongue tingling, & mouth feeling wierd, light headache
Swelling in right leg 2 weeks later. 4 weeks later extreme swelling in both legs. Pain and extreme inflammation in knees and legs. 6 weeks later extreme swelling in hands, face, and legs.
Guillain-Barre Syndrome, paralysis, immunoglobulin treatments all but feet/stamina recovered in about 2 mo w/ therapy. Some lower neck pain, balance, still unrecovered. Feet in constant pain, can't walk as well, balance off.
Herpes Zoster; Post Herpetic Neuralgia; vision problems; Information has been received from a lawyer referring to a female patient of unknown age regarding a case in litigation. Information about concurrent condition, history condition and concomitant medication was not reported. In or around 23-JUN-2016, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (strength, dose, route, anatomical location, lot# and expiration date unknown) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after receiving zoster vaccine live (ZOSTAVAX), the patient suffered vision problems and subsequent facial pain, burning, and itching and was diagnosed with herpes zoster and post herpetic neuralgia. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms had resulted in physical limitations not present prior to using zoster vaccine live (ZOSTAVAX). The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of wrongful conduct, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The patient also had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of vision problems, herpes zoster and post herpetic neuralgia was considered as not recovered and causal relationship was assessed as related.  ALL events of vision problems, herpes zoster and post herpetic neuralgia were considered as disability by the lawyer.
shots 19MAY low grade fever 20MAY-21MAY;on 23MAY t105 w/APAP, ER 24MAY, MD gave Motrin fever better;wouldn't eat,listless;so took back to ER 26MAY put on amoxil for poss sore throat, rash broke out 28MAY
Sedation, Myalgia, NauseaVomiting, fatigue and pain at the injection site. Narrative:  Other Relevant History:
Severe pain at injection site and fever, both lasting  approximately 6 hours. Treated with aspirin which reduced the symptoms.
Pt describes muscle pain when she moves the arm. She said it radiates down to elbow now to wrist. Pt saw PCP and diagnosed as frozen shoulder. She has follow up with orthopedic do do scans, etc.
Developed the chills, fever, fever blisters on and in mouth and in nose; severe head cold, runny nose and eyes,; swollen painful throat and hoarseness.  Unable to work due to symptoms and was off for one week.  Have developed reactions after the flu vaccine for the past few years and the reactions have become worse.  Afraid that next reaction may be anaphylactic in nature.
Dizziness & NauseaVomiting Narrative:  employee was taken to ER due to being off hours of OCC health. Was given IV fluids and Zofran form emesis.  Other Relevant History:
Soreness, couldn't lift arm above shoulder for about 3 days. Bruising started on 3rd of 4th day. No treatment needed.
PATIENT RECEIVED VACCINE THAT EXPERIENCED A TEMPERATURE EXCURSION, VACCINE WAS KEPT IN THE REFRIGERATOR FOR MORE THAN 30 DAYS. PATIENT DID NOT REPORT AND REACTION.
Diffused macular red rash with some papules on torso, back and shoulders. Fever of 100.4.
Member received Twinrix, ppd, and flu mist on 8 December 2007. A couple of days later patient C/O rash on face, neck, and upper body. Rash lasted 7 to 10 days.
I had the covid booster shot , that night developed a headache, chills and could not sleep.on Wednesday, that night I had a headache and t chills and sleeplessness.  Husband said I was very hot to touch. I tool a Tylenol and 5mg.Benadryl.  Dec. 19 headache and muscle pain. That evening a rash under breast developed,  Dec 10,  headache persisted till morning, rash con tuned to grow to legs and arms and up neck  except back.  They are Red, bumps and have a warm feeling.
Arm soreness; Drowsy; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PAIN IN EXTREMITY (Arm soreness) and SOMNOLENCE (Drowsy) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm soreness) and SOMNOLENCE (Drowsy). At the time of the report, PAIN IN EXTREMITY (Arm soreness) and SOMNOLENCE (Drowsy) outcome was unknown.            The patient's concomitant medication was not reported. It was reported that there were no unusual symptoms. The patient was feeling fine. No treatment information was provided.   This case was linked to MOD-2021-013316, MOD-2021-013316 (Patient Link).
Started experiencing a blocked eustachian tube on my right ear about 3 hours after receiving the vaccine. It is still ongoing despite trying to pop it thru yawning, chewing, and blowing out my nose while pinched.
Erythema at site of injection up to 15 cm. Peak with underlying induration almost entire extent of quad. (right).
On 3/21/2021 I woke up with sudden bad left lower back pain that radiated down the lateral left thigh. It continued to get worse as the week wore on. I could not bend over, lie down or sit for very long without severe discomfort. I ended up seeing a chiropractor within the week who has been treating the problem over this past month.  X rays were taken. I have been treating it with ice, ibuprofen, and aspirin.
Fever, headache, nausea, redness, swelling and pain in the upper arm, chills, faster heartbeat, dizziness, constipation, felt weak, for 10 days.
Fever, chills, fatigue (overnight, but gone in the am), heart palpitations , chest tightness and feeling out of breath: off and on for 30-60 mins at a time during the day and laying down at night. Goes away with exercise, but returns afterwards. I went to urgent care and had an EKG which was normal. Advised to see a cardiologist if they continued. Palpitations lasted about a week then went away. In 6/7 they returned.
Right after the injection patient developed a burning arm pain that radiates down arm and into hand also sometimes radiates into neck.  Has not resolved for > 3 months and started directly after shot given
Approx 4pm 1-31-2021, I began to feel aching and weak.  About 5 min later severe chills and fever ensued.  Fever was 101.8 F.  Extreme fatigue.  Went to bed at 6:30pm as headache came on also.  Middle of the night woke up soaking we as fever broke.  Feel just a bit aching and fatigued today 2/1/2021
Showed up at an ED with fever and pain at the site on 6/15/18.....Diagnosed with UTI, Sepsis, Rash, Tachycardia.
arm soreness; fatigue; headache; difficulty breathing; tachycardia; heart racing; flush; pins and needles; A spontaneous report was received from a nurse concerning a 37 year old female patient.  The patient's medical history was not provided.  No relevant concomitant medication was reported.  On 02Jan2021, the patient received the first of their first planned doses of mRNA-1273 (lot number 039K2A20) intramuscularly for prophylaxis of COVID-19 infection.  On 02Jan2021, the patient experienced  the feeling of pins and needles over her face and chest, a little flushed, heart racing, difficulty breathing, heart rate 108.  On 03Jan2021, the patient experienced arm soreness, fatigue, and headache.  No treatment was reported.  Action taken with the mRNA-1273 was not reported.  The outcome of the events of tachycardia, flushing, palpitations,  paraesthesia, dyspnoea, pain in extremity, fatigue, and headache, was considered resolved.; Reporter's Comments: This case concerns a 37 year old, female patient, who experienced a non-serious unexpected event of tachycardia, palpitations, flushing, paraesthesia, dyspnea, pain in extremity, and non-serious expected events of fatigue, and headache. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested.
Broke out on the whole face, neck, arm and hand/looked like he had a mix of Measleas and Rubella/that is how bad his rash was; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH MORBILLIFORM (Broke out on the whole face, neck, arm and hand/looked like he had a mix of Measleas and Rubella/that is how bad his rash was) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH MORBILLIFORM (Broke out on the whole face, neck, arm and hand/looked like he had a mix of Measleas and Rubella/that is how bad his rash was) (seriousness criterion hospitalization). At the time of the report, RASH MORBILLIFORM (Broke out on the whole face, neck, arm and hand/looked like he had a mix of Measleas and Rubella/that is how bad his rash was) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.   Treatment information was not provided.  Very limited information regarding the events has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding the events has been provided at this time.  Further information has been requested.
p/vax pt arm felt sore;by noc time swollen & aching;ice applied;second noc heat applied;APAP & DPH taken
Left arm muscle cramps from shot side to ring and middle fingers right after the shot. Sore warm itchy on site.  Headaches.  Woke up from heart racing to the throat with a full face sweat. (Could hear and feel that the blood rush up like waves
This spontaneous report was received from a patient's mother concerning to an 11 years old female patient. The patient received her first dose of GARDASIL intramuscular (dose and lot not reported) in JUN-2012 6 months ago. No other co-suspects were reported. No concomitant medications were reported. The patient had not received her second dose at this time. The outcome of the event was unknown. Additional information has been requested.
Patient received second dose of Pfizer on 9/7/2021 and called on 9/8/2021 to report a "golf-ball sized lump" under her right armpit.
I have developed skin rashes that reoccur on a regular basis. I received my first anthrax shot on 10/21/1999 and continued the series that ended with shot 4 on 04/25/2000. My rashes began shortly there after on my torso, neck, back and arms along with soreness, swelling, itching at the site of injection.
Fever up yo 100.4,  achey, chills for c 24 hours
This spontaneous report as received from a physician refers to a 60 years old male patient with high blood pressure and high cholesterol. The patient had a history of prostate cancer. The patient was vaccinated a dose of with ZOSTAVAX on 29-JAN-2013. No other co-suspects were reported. No concomitant medications were reported. The patient experienced itching later the same day as vaccination, on 29-JAN-2013. The next day the patient developed classic shingles on his right abdomen wrapping around to his back, dermatome T10 or T11. The patient was treated with VALTREX and prednisone. The outcome of itching and classic shingles on his right abdomen wrapping around to his back, dermatome T10 or T11 was reported as not recovered/not resolved. The relatedness for classic shingles on his right abdomen wrapping around to his back, dermatome T10 or T11 and itching was unknown for ZOSTAVAX. Additional information has been requested.
Two weeks after second Moderna vaccine, 3 days of severe headaches involving entire head.  Heart pain, flipping, and pounding for one month.  Lower body pain, especially in legs continuing to today.  Shortness of breath for 2 weeks, Abdominal pain for one month.  Rash and hives, some continuing to today.
Patient reports getting both vaccines in same arm on 10/11/2021. Patient reports needing to go to the hospital on 10/14/2021 due to increased heart rate, chest pain, and difficulty breathing.
Booster; Tested positive for COVID-19; mild symptoms of COVID-19 (scratchy throat and mild congestion); Tested positive for COVID-19; mild symptoms of COVID-19 (scratchy throat and mild congestion); This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 45 year-old female patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Household member contracted COVID-19 and was a close contact of the patient" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1; MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (Dose 2; MANUFACTURER UNKNOWN), for COVID-19 immunization. The patient was in good health. The following information was reported: IMMUNISATION (medically significant), outcome "unknown", described as "Booster"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Tested positive for COVID-19; mild symptoms of COVID-19 (scratchy throat and mild congestion)". Event took place after use of product, 25 days after receiving third dose (booster) of BNT162B2. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive.  The lot number for bnt162b2 was not provided and will be requested during follow up.
About 6 hrs after receiving injection, patient experienced Rt leg numbness which rose to trunk and became intense pain lasting several hours. All symptoms were resolved by morning and have not returned - no treatment given.
10/15/03 Fever 101, arm sore. 10/16/03 Fever all day, arm sore/red. 10/19/03 Fever 104, arm red, sore and swollen.
ACUTE HYPOXEMIC RESPIRATORY FAILURE ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE RESPIRATORY FAILURE, UNSPECIFIED ACUITY
vomit, diarrhea, chills, lost consciousness, BP drop. Paramedics brought to ER. Given fluids, EKG,  and lab tests to make sure it wasn't heart related. Tests came back normal.